Symbiotec Pharmalab stands out as the preferred long-term pick, backed by SBI Securities' 'Subscribe' rating and Master Capital's positive view on its specialised business.
Gold loan market gets crowded: Will new entrants dull incumbents' sheen?
Index funds gain ground as ETFs lose share of India's passive fund market
India's economic growth likely slowed to 7.1% in April-June quarter: Poll
Stock Market LIVE: Sensex falls 100 pts, Nifty around 24,150; bank shares weigh
Skyways Air vs Symbiotec vs Hy-Tech Analysts pick their top IPO bet
Gold loan market gets crowded Will new entrants dull incumbents' sheen?
Closing Auction System set for first monthly derivatives expiry test
Brokerage bets HDFC Life, Home First Finance are Shrikant Chouhan's top picks
The Compass Dixon Technologies set to gain from new mobile phone manufacturing scheme